skip to main content
Tipo de recurso Mostra resultados com: Mostra resultados com: Índice

Experience with veno-venous ecmo in patients with adult respiratory distress syndrome secondary to viral pneumonia. Case series

Figueredo, Antonio ; Salazar, Leonardo ; Pizarro, Camilo E. ; Orozco-Levi, Mauricio ; Botia, Maria M.

Colombian journal of anesthesiology (Inglâes), 2020-09, Vol.48 (4) [Periódico revisado por pares]

SCARE-Sociedad Colombiana de Anestesiología y Reanimación

Texto completo disponível

Citações Citado por
  • Título:
    Experience with veno-venous ecmo in patients with adult respiratory distress syndrome secondary to viral pneumonia. Case series
  • Autor: Figueredo, Antonio ; Salazar, Leonardo ; Pizarro, Camilo E. ; Orozco-Levi, Mauricio ; Botia, Maria M.
  • Assuntos: ANESTHESIOLOGY
  • É parte de: Colombian journal of anesthesiology (Inglâes), 2020-09, Vol.48 (4)
  • Descrição: Introduction: The use of extracorporeal membrane oxygenation (ECMO) has increased exponentially in recent years and has shown to be effective in treating adult respiratory distress syndrome (ARDS) secondary to H1N1-related pneumonia. However, evidence remains controversial. This study describes a case series of ECMO in ARDS secondary to viral pneumonia. Methods: A search was conducted in the ECMO database of Fundación Cardiovascular de Colombia for the 2013-2017 period. A case series report was written of patients diagnosed with ARDS secondary to confirmed or suspected viral pneumonia. Results: Nineteen patients with ECMO support and ARDS due to viral pneumonia were included in the study. The survival rate upon discharge was 11 patients (58%) and weaning from ECMO support was successful in 13 patients (68%). Hemorrhagic complications were the most frequent: gastrointestinal bleeding, 10 patients (53%); intracranial bleeding, 2 (10%); alveolar hemorrhage, 2 (10%);’ hemothorax requiring thoracostomy with chest tube drainage, 2 (10%); cannulation site bleeding, 9 patients (47%); and surgical site bleeding in 3 patients (25%) who required tracheostomy. Other complications were: pneumothorax, 1 patient (5%); sepsis, 6 patients (32%); and growth of microorganisms in bronchial lavage, 6 patients (32%). Conclusions: This study supports the use of veno-venous ECMO to achieve a higher survival rate than expected in patients with severe ARDS and refractory hypoxemia secondary to viral pneumonia. Early initiation of the therapy should improve overall results.
  • Editor: SCARE-Sociedad Colombiana de Anestesiología y Reanimación
  • Idioma: Inglês;Português

Buscando em bases de dados remotas. Favor aguardar.